Intracoronary Ultrasound in Assessing Efficacy of Cardiovascular Drugs

Stephen J. Nicholls, Kiyoko Uno, E. Murat Tuzcu, Steven E. Nissen

Research output: Contribution to journalReview ArticleResearchpeer-review


Despite substantial advances in our approach to prevent cardiovascular disease, there is an ongoing need to develop new therapeutic strategies to achieve more effective reduction in cardiovascular risk. Intravascular ultrasound imaging of the coronary arteries has been increasingly employed in clinical trials to evaluate the impact of medical therapies on the progression of atherosclerosis. In addition to the ability to assess whether novel agents can slow disease progression, these studies have provided a number of important insights into the factors that underlie the natural history of disease progression.

Original languageEnglish
Pages (from-to)190-196
Number of pages7
JournalCurrent Cardiovascular Imaging Reports
Issue number4
Publication statusPublished - 9 Jun 2010
Externally publishedYes


  • Atherosclerosis
  • Cardiovascular disease
  • Clinical trials
  • Intravascular ultrasound
  • Risk factors

Cite this